Related Content
Search Google Scholar for:
|
|
Science 16 December 1988:
Vol. 242. no. 4885, pp. 1575 - 1578
DOI: 10.1126/science.3201248
|
|
Articles
Science, Vol 242, Issue 4885, 1575-1578
Copyright © 1988 by American Association for the Advancement of Science
Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression
MB Rosenberg,
T Friedmann,
RC Robertson,
M Tuszynski,
JA Wolff,
XO Breakefield,
and
FH Gage
Department of Pediatrics, University of California School of Medicine, La Jolla 92093.
Fibroblasts were genetically modified to secrete nerve growth factor (NGF) by infection with a retroviral vector and then implanted into the brains of rats that had surgical lesions of the fimbria-fornix. The grafted cells survived and produced sufficient NGF to prevent the degeneration of cholinergic neurons that would die without treatment. In addition, the protected cholinergic cells sprouted axons that projected in the direction of the cellular source of NGF. These results indicate that a combination of gene transfer and intracerebral grafting may provide an effective treatment for some disorders of the central nervous system.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Cholinergic systems in progressive supranuclear palsy.
- N. M. Warren, M. A. Piggott, E. K. Perry, and D. J. Burn (2005)
Brain
128, 239-249
| Abstract »
| Full Text »
| PDF »
- Progenitor Cell Biology: Implications for Neural Regeneration.
- M. F. Mehler and J. A. Kessler (1999)
Arch Neurol
56, 780-784
| Abstract »
| Full Text »
| PDF »
- Transplants of Fibroblasts Genetically Modified to Express BDNF Promote Regeneration of Adult Rat Rubrospinal Axons and Recovery of Forelimb Function.
- Y. Liu, D. Kim, B. T. Himes, S. Y. Chow, T. Schallert, M. Murray, A. Tessler, and I. Fischer (1999)
J. Neurosci.
19, 4370-4387
| Abstract »
| Full Text »
| PDF »
- Review : Gene Therapy: Applications to the Neurosciences and to Neurological Disease.
- M. H. Tuszynski (1998)
Neuroscientist
4, 398-407
| Abstract »
| PDF »
- Bcl-xL protects adult septal cholinergic neurons from axotomized cell death.
- U. Blomer, T. Kafri, L. Randolph-Moore, I. M. Verma, and F. H. Gage (1998)
PNAS
95, 2603-2608
| Abstract »
| Full Text »
| PDF »
- Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells.
- E. D. Clarkson, F. G. L. Rosa, J. Edwards-Prasad, D. A. Weiland, S. E. Witta, C. R. Freed, and K. N. Prasad (1998)
PNAS
95, 1265-1270
| Abstract »
| Full Text »
| PDF »
- Gene Transfer to Cerebral Blood Vessels After Subarachnoid Hemorrhage.
- M. G. Muhonen, H. Ooboshi, M. J. Welsh, B. L. Davidson, and D. D. Heistad (1997)
Stroke
28, 822-829
| Abstract »
| Full Text »
- Implants of Encapsulated Human CNTF-Producing Fibroblasts Prevent Behavioral Deficits and Striatal Degeneration in a Rodent Model of Huntington''s Disease.
- D. F. Emerich, M. D. Lindner, S. R. Winn, E.-Y. Chen, B. R. Frydel, and J. H. Kordower (1996)
J. Neurosci.
16, 5168-5181
| Abstract »
| Full Text »
| PDF »
- Gene Therapy for Neurologic Disease.
- S. T. Suhr and F. H. Gage (1993)
Arch Neurol
50, 1252-1268
| Abstract »
| PDF »
- Survival of adult basal forebrain cholinergic neurons after loss of target neurons.
- M. Sofroniew, N. Galletly, O Isacson, and C. Svendsen (1990)
Science
247, 338-342
| Abstract »
| PDF »
- Mechanisms Regulating Cell Number and Type in the Mammalian Central Nervous System.
- R. McKay, N. Valtz, M. Cunningham, and T. Hayes (1990)
Cold Spring Harb Symp Quant Biol
55, 291-301
| Abstract »
| PDF »
- Progress toward human gene therapy.
- T Friedmann (1989)
Science
244, 1275-1281
| Abstract »
| PDF »
|
|
